Elsevier

European Journal of Cancer

Volume 31, Issue 9, September 1995, Pages 1425-1427
European Journal of Cancer

Original paper
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast

https://doi.org/10.1016/0959-8049(95)00283-OGet rights and content

Abstract

The 10-year results of 300 patients with ductal carcinoma in situ (DCIS) without microinvasion are reported; 167 treated with mastectomy and 133 treated with excision and radiation therapy. There was a significant difference in disease-free survival at 10 years, in favour of those treated with mastectomy, 98% versus 81% (P = 0.0004). Multivariate analysis confirmed nuclear grade as the only significant predictor of local recurrence (P = 0.02) or invasive local recurrence (P = 0.03) in patients with DCIS treated with excision and radiation therapy. There was no difference in breast cancer-specific survival or overall survival between the two treatment groups.

References (15)

  • A Recht et al.

    Ductal carcinoma in situ

    Lancet

    (1994)
  • MD Lagios

    Duct carcinoma in situ: Pathology and treatment

    Surg Clin N Am

    (1990)
  • B Fisher et al.

    Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

    N Engl J Med

    (1993)
  • ER Frykberg et al.

    Overview of the biology and management of ductal carcinoma in situ of the breast

    Cancer

    (1994)
  • HJG Bloom et al.

    Histologic grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years

    Br J Cancer

    (1957)
  • DL Page et al.

    Carcinoma in situ (CIS)

  • DL Slamon et al.

    Studies of the HER-2/ neu proto-oncogene in human breast and ovarian cancer

    Science

    (1989)
There are more references available in the full text version of this article.

Cited by (210)

  • In situ carcinomas of the breast: Ductal carcinoma in situ and lobular carcinoma in situ

    2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
  • Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions

    2017, Progress in Molecular Biology and Translational Science
    Citation Excerpt :

    As mentioned previously, mastectomy was historically the treatment of choice for DCIS when its most common presentation was as a palpable mass. Outcomes after mastectomy for DCIS are excellent, with studies showing 98%–99% disease-free survival.17,121,122 The excellent survival rates for DCIS has led to more conservative therapy, with rates of mastectomy decreasing in favor of breast conservation therapy.17,123,124

View all citing articles on Scopus
1

A. Barth was a visiting fellow in Medical Oncology from the University of Bern.

2

D.N. Poller was a visitng fellow in Pathology from City Hospital, Nottingham, U.K.

View full text